← Back to Intel
Insider ActivitySPRY
Karas Eric, Chief Commercial Officer at ARS Pharmaceuticals, Inc., sold $250K of SPRY
Updated Jun 19, 2026
Karas Eric
Chief Commercial Officer
ARS Pharmaceuticals, Inc. ·
$SPRY
Transaction Details
| Insider | Karas Eric |
|---|---|
| Title | Chief Commercial Officer |
| Company | ARS Pharmaceuticals, Inc. |
| Ticker | SPRY |
| Transaction Type | Sale |
| Transaction Date | 2026-06-12 |
| Shares Traded | 25,000 |
| Price Per Share | $10 |
| Total Value | $250K |
| Filed Date | 2026-06-12 |
| Accession Number | 0001951287-26-000004 |
Ownership Context
| Shares Owned After Transaction | 12,176 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001951287-26-000004
Other Insider Trades — SPRY
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Karas Eric | Chief Commercial Officer | traded | $38K | 2026-06-12 |
| Fitzpatrick Alexander A | Chief Legal Officer | sold | $34K | 2026-06-12 |
Other Trades by Karas Eric
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | traded | $38K | 2026-06-12 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for SPRY — ARS Pharmaceuticals, Inc. →
Track SPRY insider activity in real time on The Wire →
Get alerts when Karas Eric files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 19, 2026 at 07:01 UTC